The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Thursday, September 10, 6:00 pm through Friday, September 11, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Two-color flow cytometric analysis of CXCR5 (CD185) expression on human peripheral blood lymphocytes. Whole blood was stained with FITC Mouse Anti-Human CD19 antibody (Cat. No. 555412/560994) and either BD Horizon™ BB700 Rat IgG2b, κ Isotype Control (Cat. No. 566418; Left Plot) or BD Horizon BB700 Mouse Anti-Human CXCR5 (CD185) antibody (Cat. No. 566469/566470; Right Plot). Erythrocytes were lysed with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899). Two-color flow cytometric dot plots showing the correlated expression of CXCR5 (CD185) [or Ig Isotype control staining] versus CD19 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometric analysis was performed using a BD FACSCelesta™ Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet for the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
When setting up compensation, it is recommended to compare spillover values obtained from cells and BD™ CompBeads to ensure that beads will provide sufficiently accurate spillover values.
For optimal results, it is recommended to perform two washes after staining with antibodies. Cells may be prepared, stained with antibodies and washed twice with wash buffer per established protocols for immunofluorescent staining, prior to acquisition on a flow cytometer. Performing fewer than the recommended wash steps may lead to increased spread of the negative population.
The RF8B2 monoclonal antibody specifically binds to the human CXC chemokine receptor, CXCR5. CXCR5 (also known as CD185, BLR-1 NLR and MDR15), a seven transmembrane, G-protein-coupled receptor, is the specific receptor for CXC chemokine, CXCL13/BLC/BCA-1. In peripheral blood, CXCR5 expression is restricted to B lymphocytes and a small subset of CD4+ and CD8+ lymphocytes. The restricted expression pattern of CXCR5 on B cells and follicular T helper cells (Tfh) suggests that this receptor functions as a regulator of B and T cell migration. Stimulation of T cells with anti-CD3 monoclonal antibody leads to the down-regulation of CXCR5.
The antibody was conjugated to BD Horizon BB700, which is part of the BD Horizon Brilliant™ Blue family of dyes. It is a polymer-based tandem dye developed exclusively by BD Biosciences. With an excitation max of 485 nm and an emission max of 693 nm, BD Horizon BB700 can be excited by the 488 nm laser and detected in a standard PerCP-Cy™5.5 set (eg, 695/40-nm filter). This dye provides a much brighter alternative to PerCP-Cy5.5 with less cross laser excitation off the 405 nm and 355 nm lasers.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.